Subtype
Extrahepatic Bile Duct Neoplasm
CI-CAN-00002645Explore in graph →
Non-malignant30 active trials
- NCIt
- C4441
Loading cancer entity…
Subtype
CI-CAN-00002645Explore in graph →
Clinical trials
162 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02856568 | Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma | withdrawn | Phase 1 | 0 | Mayo ClinicOTHER | 1 | May 30, 2017 | clinicaltrials |
Data updated 22 days agoSource updated May 30, 2017source: clinicaltrials